Stefan Ryser

1.1k total citations
15 papers, 923 citations indexed

About

Stefan Ryser is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Stefan Ryser has authored 15 papers receiving a total of 923 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Stefan Ryser's work include Immune Cell Function and Interaction (5 papers), CAR-T cell therapy research (4 papers) and T-cell and B-cell Immunology (4 papers). Stefan Ryser is often cited by papers focused on Immune Cell Function and Interaction (5 papers), CAR-T cell therapy research (4 papers) and T-cell and B-cell Immunology (4 papers). Stefan Ryser collaborates with scholars based in United States, Switzerland and Netherlands. Stefan Ryser's co-authors include Jürgen Drews, Harald von Boehmer, Yasushi Uematsu, Anton Berns, Paul Krimpenfort, Zlatko Dembić, Peter Borgulya, Michael Steinmetz, Michel O. Steinmetz and Rolien de Jong and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and The EMBO Journal.

In The Last Decade

Stefan Ryser

15 papers receiving 871 citations

Peers

Countries citing papers authored by Stefan Ryser

Since Specialization

Citations

This map shows the geographic impact of Stefan Ryser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Ryser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Ryser more than expected).

Fields of papers citing papers by Stefan Ryser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Ryser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Ryser. The network helps show where Stefan Ryser may publish in the future.

Co-authorship network of co-authors of Stefan Ryser

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Ryser. A scholar is included among the top collaborators of Stefan Ryser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Ryser. Stefan Ryser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Phase 1 study of the pharmacokinetics and clinical proof-of-concept activity of a biofilm-disrupting human monoclonal antibody in patients with chronic prosthetic joint infection of the knee or hip 2024 ·Antimicrobial Agents and Chemotherapy ·Janet D. Conway, Ronald E. Delanois, Michael A. Mont, Alexandra I. Stavrakis, Edward J. McPherson, (unknown), Stephen J. Incavo, Daniel A. Oakes, (unknown), John S. Adams, (unknown), (unknown), Anton Leighton, Stefan Ryser, Lawrence M. Kauvar, Nicholas M. Bernthal	9
2	Human antibody repertoire frequently includes antibodies to a bacterial biofilm associated protein 2019 ·PLoS ONE ·Stefan Ryser, (unknown), Angeles Estellés, Lawrence M. Kauvar	9
3	High affinity anti-TIM-3 and anti-KIR monoclonal antibodies cloned from healthy human individuals 2017 ·PLoS ONE ·Stefan Ryser, Angeles Estellés, (unknown), Lawrence M. Kauvar, Mikhail L. Gishizky	8
4	A Human Biofilm-Disrupting Monoclonal Antibody Potentiates Antibiotic Efficacy in Rodent Models of both Staphylococcus aureus and Acinetobacter baumannii Infections 2017 ·Antimicrobial Agents and Chemotherapy ·Yan Q. Xiong, Angeles Estellés, Liang Li, Wessam Abdelhady, (unknown), Arnold S. Bayer, (unknown), Anton Leighton, Stefan Ryser, Lawrence M. Kauvar	47
5	A High-Affinity Native Human Antibody Disrupts Biofilm from Staphylococcus aureus Bacteria and Potentiates Antibiotic Efficacy in a Mouse Implant Infection Model 2016 ·Antimicrobial Agents and Chemotherapy ·Angeles Estellés, Anne-Kathrin Woischnig, Keyi Liu, Robert A. Stephenson, (unknown), (unknown), Jianzhong Zhang, (unknown), Yifan Yang, Reyna J. Simon, (unknown), (unknown), Anton Leighton, Stefan Ryser, Nina Khanna, Lawrence M. Kauvar	63
6	Drug approvals and failures: implications for alliances 2008 ·Nature Reviews Drug Discovery ·(unknown), Stefan Ryser	31
7	Drug Development: The role of innovation in drug development 1997 ·Nature Biotechnology ·Jürgen Drews, Stefan Ryser	112
8	Pharmaceutical innovation between scientific opportunities and economic constraints 1997 ·Drug Discovery Today ·Jürgen Drews, Stefan Ryser	21
9	Classic drug targets 1997 ·Nature Biotechnology ·Jürgen Drews, Stefan Ryser	18
10	Innovation Deficit in the Pharmaceutical Industry 1996 ·Drug Information Journal ·Jürgen Drews, Stefan Ryser	61
11	Functional expression of a human TCRβ gene in transgenic mice 1993 ·International Immunology ·Joachim Rothe, Stefan Ryser, (unknown), (unknown), Horst Bluethmann	3
12	Transgenic mice to study T-cell receptor gene regulation and repertoire formation 1989 ·Genome ·Michael Steinmetz, Horst Blüthmann, Stefan Ryser, Yasushi Uematsu	3
13	In transgenic mice the introduced functional T cell receptor β gene prevents expression of endogenous β genes 1988 ·Cell ·Yasushi Uematsu, Stefan Ryser, Zlatko Dembić, Peter Borgulya, Paul Krimpenfort, Anton Berns, Harald von Boehmer, Michael Steinmetz	316
14	Transcription of T cell receptor beta-chain genes is controlled by a downstream regulatory element. 1988 ·The EMBO Journal ·Paul Krimpenfort, Rolien de Jong, Yasushi Uematsu, Zlatko Dembić, Stefan Ryser, Harald von Boehmer, Michel O. Steinmetz, Anton Berns	170
15	Early expression of a T-cell receptor beta-chain transgene suppresses rearrangement of the V gamma 4 gene segment. 1988 ·Proceedings of the National Academy of Sciences ·Harald von Boehmer, Marc Bonneville, I. Ishida, Stefan Ryser, (unknown), Richard T. Smith, Hiroyuki Kishi, B Scott, Paweł Kisielow, Susumu Tonegawa	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact